Behaviors and Mental Disorders

All Conditions

Symptoms and General Pathology

Anxiety Disorders

Depressive Disorder

Fatigue

Depression

Cognitive Dysfunction

Mental Fatigue

Cognition Disorders

Neurocognitive Disorders

Mental Disorders

Psychotic Disorders

Behavioral Symptoms

The proposed intervention is an 8-week 'Coping with Brain Fog' program for cancer survivors, adapted for AYAs with cancer, with one 90-minute group session per week. The intended group size for the program is 8-12 participants. The program was developed to be delivered in person, however for the purposes of this study it will be conducted in a virtual setting. The overall goals of the program are to educate participants about cancer-related brain fog and enhance their cognitive function and wellbeing. To accomplish this, the program is segmented into three main components: memory skills, task management, and psychological wellbeing. For each component, participants are systematically introduced to evidence-based strategies to cumulatively build a repertoire of cognitive tools designed to reduce the impact of cancer-related brain fog. The program uses a manual and participant materials that are copyrighted by Maximum Capacity Inc.

'Coping with Brain Fog' program

Cancer-related cognitive problems, also known as "brain fog", have a significant impact on patients with cancer and cancer survivors. Previous studies indicate that cancer and cancer treatments can negatively affect memory, attention and thinking abilities. Adolescents and young adults (AYAs) are individuals with a cancer diagnosis, who are currently between 18 to 40 years old. These individuals are especially vulnerable to brain fog symptoms due to the effect these symptoms have on their education, employment, health behaviors, mental health, and social relationships. There is a clear need for programming directed at brain fog symptoms among AYAs with cancer diagnoses. The 'Coping with Brain Fog' program, developed by Maximum Capacity Inc., is an eight-week group program that has been designed to educate patients about their brain fog symptoms and develop strategies to manage these symptoms. In this study the investigators will aim to determine the feasibility of adapting the 'Coping with Brain Fog' program to the virtual setting for AYAs with cancer during the COVID-19 pandemic. The investigators will also aim to explore the efficacy of the program on cognitive functioning and symptoms of anxiety, depression and fatigue. This study is an important step towards finding ways to treat brain fog symptoms in cancer patients, and could help guide future studies and programs.

Background: Cancer-related cognitive deficits, also known as "brain fog", are a well-established morbidity among patients with cancer and cancer survivors. Associations between cancer or cancer treatment with difficulties in short-term and working memory, attention, processing speed, verbal fluency, and executive function have been previously described. Adolescents and young adults (AYA) are individuals who have had a cancer diagnosis and are currently between 18 to 40 years of age. Mitigating cognitive symptoms in the AYA population is especially important, as these cognitive symptoms affect education and employment, health behaviors, mental health, and social relationships. Further, as more AYAs with cancer survive their cancer and live into adulthood, improving their quality of life is even more vital. There is a clear need for programming directed at brain fog symptoms among AYAs with a cancer diagnosis.

Objective: The primary objective of this study is to determine the feasibility and acceptability/satisfaction of a virtual 'Coping with Brain Fog' intervention to AYAs with cancer during the COVID-19 pandemic. Secondary objectives of the study are to determine the preliminary effect of the intervention on the cognitive functioning and symptoms of distress (anxiety/depression/fatigue) of AYAs with cancer.

Methods: This prospective pilot study will involve an 8-week virtual "Coping with Brain Fog" program, with one 90-minutes session per week. The 'Coping with Brain Fog' program, developed by Maximum Capacity Inc., has been designed as an in-person group program to educate participants about brain fog and help them enhance their cognition and overall wellbeing. Sessions are designed to enhance memory, task management, and psychological wellbeing skills. Sessions will be delivered over Zoom in a group setting by a Master's-prepared registered social worker and AYA psychosocial oncology clinician at CancerCare Manitoba. Individuals who are between the ages of 18-40 and are (a) diagnosed with any type or stage of cancer, (b) seeking intervention for self-reported symptoms of brain fog (such as poor memory, mental slowness, or task insufficiency), and (c) currently living in Manitoba, Northwestern Ontario or Nunavut, will be eligible for this study. Before starting the intervention, the study participants will be sent a survey link to collect background patient information and measure self-reported cognitive function and symptoms of distress. The participants will also complete a post-intervention questionnaire to measure self-reported cognitive function, symptoms of distress, and satisfaction within one week of completing the intervention and at 6-8 weeks after the intervention. Semi-structured exit phone interviews will be conducted with the participants within two weeks of completing the intervention to collect their narrative feedback and experiences with the intervention.

Significance: This pilot project will help determine the feasibility and acceptability/satisfaction of a virtual 'Coping with Brain Fog' program and measure its preliminary effects on cognitive function and symptoms of distress among AYAs with cancer.

Pilot study of the virtual 'Coping with Brain Fog' intervention for AYAs with cancer living in Manitoba.

Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer

Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Adolescents and Young Adults With Cancer

The investigators will measure the adherence to the intervention by measuring attendance at the weekly sessions. The intervention will be considered feasible if 60% of participants do not miss the first two sessions and any two consecutive sessions.

The participants' satisfaction with the program will be measured using The Client Satisfaction Questionnaire (CSQ), an 8-item self-report scale which will be administered at the end of the intervention to assess the participant satisfaction. Each item on this scale is scored from 1 to 4, generating a total score ranging from 8 to 32. A total score of 8-20 indicates low satisfaction, whereas total scores of 21-26 and 27-32 indicate medium and higher satisfaction, respectively.

The investigators will measure perceived cognitive functioning before and after the intervention using the Functional Assessment of Cancer Therapy (FACT)-Cognitive Function Scale, a 37-item self-report scale, which will be administered to measure subscales of perceived cognitive impairments, impact of perceived cognitive impairments on quality of life, comments from others, and perceived cognitive abilities. Each item on the subscales is scored from 0 to 4, to generate a total score for each subsection. These subscale scores will be aggregated to give a final score between 0-20, with a higher score being associated with better quality of life.

The investigators will measure perceived cognitive functioning before and after the intervention using the Cognitive component of the Cancer Distress Scales for Adolescents and Young Adults (CDS-AYA), an 8-item self-report scale, which will be administered before and at the end of the intervention to measure distress related to cognitive problems. Each item on this scale is scored from 0 to 3 to generate a total score between 0-24. Raw sum scores are transformed to a score from 0 (best) to 100 (worst), with a higher score reflecting more distress.

The investigators will evaluate anxiety using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Anxiety 8a, an 8-item self-report scale. Each item on the form is scored from 0 (never) to 5 (always). Scores on each item are summed to determine a raw score, which is converted to a standardized T-score with a mean of 50 and a standard deviation (SD) of 10, with a higher score reflecting greater anxiety.

The investigators will evaluate depression using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Depression 8b, an 8-item self-report scale. Each item on the form is scored from 0 (never) to 5 (always). Scores on each item are summed to determine a raw score, which is converted to a standardized T-score with a mean of 50 and a standard deviation (SD) of 10, with a higher score reflecting greater depression.

The investigators will evaluate fatigue using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Fatigue 8a, an 8-item self-report scale. Each item on the form is scored from 0 (not at all/never) to 5 (very much/always). Scores on each item are summed to determine a raw score, which is converted to a standardized T-score with a mean of 50 and a standard deviation (SD) of 10, with a higher score reflecting greater fatigue.

The semi-structured interview conducted at the end of the intervention will explore participants' experience with the program and satisfaction

CancerCare Manitoba

University of Manitoba

Pediatric Hematologist Oncologist

Neoplasms

Skin and Connective Tissue Diseases

Breast Neoplasms

Adam Cohen, MD

Ebtehal Al Shami

The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done twice to see if changes are detected similarly on both types of measures.

Current brain fog research struggles to clearly define and measure brain fog because the changes are more subtle than typically show up on "objective" tests. These subtle changes on the tests, may not appear subtle in everyday life. This disconnect can lead to people managing cancer feeling unheard or unbelieved about their experience with brain fog. However, cognitive research outside of the cancer population has developed and tested tests that are more sensitive to cognitive changes and improvements. The goal of this initial research project is to test a more sensitive test, called the Test of Strategic Learning (TOSL), to see if it is sensitive enough to objectively measure brain fog.

One other problem with previous brain fog research is that it has not included a diverse population. Therefore, what we think we know about brain fog may not be true for everyone with brain fog. The diverse population in the DMV area that Inova serves deserves to have their experiences represented in the research.

Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning

Number of months between opening of recruitment and recruitment date of the 10th subject.

Spearman correlation coefficient between the TOSL Lessons score and the PAOFI higher level cognition subscale score.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer	NCT05115422	Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults	'Coping with Br...	18 Years - 40 Years	University of Manitoba
Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer	NCT05115422	Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults	'Coping with Br...	18 Years - 40 Years	University of Manitoba
Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer	NCT05115422	Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults	'Coping with Br...	18 Years - 40 Years	University of Manitoba
Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning	NCT05519774	Brain Fog		18 Years -	Inova Health Care Services

Spots Global Cancer Trial Database for brain fog

Every month we try and update this database with for brain fog cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for brain fog

Every month we try and update this database with for brain fog cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for brain fog cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.